Shares of Albemarle Corporation (NYSE:ALB – Get Free Report) have been given an average rating of “Moderate Buy” by the twenty-six analysts that are currently covering the firm, Marketbeat.com reports. Two research analysts have rated the stock with a sell recommendation, nine have given a hold recommendation and fifteen have given a buy recommendation to the company. The average 12-month target price among analysts that have issued ratings on the stock in the last year is $190.0435.
ALB has been the topic of several research analyst reports. Citigroup dropped their target price on shares of Albemarle from $225.00 to $175.00 and set a “buy” rating on the stock in a research report on Friday, August 7th. Jefferies Financial Group lowered their price objective on Albemarle from $244.00 to $211.00 and set a “buy” rating on the stock in a report on Tuesday, June 30th. JPMorgan Chase & Co. reduced their target price on Albemarle from $160.00 to $140.00 and set a “neutral” rating for the company in a report on Tuesday, August 25th. Berenberg Bank boosted their price target on Albemarle from $153.00 to $192.00 and gave the stock a “hold” rating in a research report on Tuesday, June 2nd. Finally, Morgan Stanley reissued a “reduce” rating and issued a $161.00 price objective on shares of Albemarle in a research note on Monday, August 10th.
View Our Latest Report on Albemarle
Institutional Trading of Albemarle
Albemarle Trading Down 1.3%
Shares of Albemarle stock opened at $113.52 on Friday. The company has a market cap of $13.40 billion, a P/E ratio of 420.47, a price-to-earnings-growth ratio of 0.67 and a beta of 1.33. Albemarle has a fifty-two week low of $78.91 and a fifty-two week high of $221.00. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.35 and a current ratio of 2.09. The firm has a 50-day simple moving average of $126.37 and a two-hundred day simple moving average of $155.80.
Albemarle (NYSE:ALB – Get Free Report) last announced its earnings results on Wednesday, August 5th. The specialty chemicals company reported $3.75 earnings per share for the quarter, topping the consensus estimate of $3.20 by $0.55. Albemarle had a return on equity of 10.96% and a net margin of 3.09%.The business had revenue of $1.74 billion during the quarter, compared to the consensus estimate of $1.61 billion. During the same period in the prior year, the company posted $0.11 EPS. The business’s quarterly revenue was up 31.1% on a year-over-year basis. As a group, equities analysts predict that Albemarle will post 11.39 earnings per share for the current fiscal year.
Albemarle Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Thursday, October 1st. Stockholders of record on Friday, September 11th will be given a $0.41 dividend. This represents a $1.64 dividend on an annualized basis and a dividend yield of 1.4%. This is a positive change from Albemarle’s previous quarterly dividend of $0.41. The ex-dividend date is Friday, September 11th. Albemarle’s dividend payout ratio (DPR) is currently 607.41%.
About Albemarle
Albemarle Corporation (NYSE:ALB) is a global specialty chemicals company that develops, manufactures and markets products used in energy storage, transportation, electronics, construction, agriculture, pharmaceuticals and other industrial applications. The company operates through three principal businesses: Energy Storage, Specialties and Ketjen.
Albemarle is one of the major producers of lithium and lithium compounds, including lithium carbonate and lithium hydroxide, which are used in rechargeable batteries for electric vehicles, portable electronics and stationary energy storage systems.
See Also
- Five stocks we like better than Albemarle
- Running on Empty: 3 Energy Plays for Europe’s Deep Freeze
- 3 Healthcare Stocks for 3 Stages of Life
- Curaleaf Tries To Roll Up Aurora In a Hostile Cannabis Bid
- MarketBeat’s Most Downgraded Stocks in Q3: 2 Look Cheap, 1 Looks Risky
Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.
